Selexipag
Selexipag is a selective non-prostanoid IP prostacyclin receptor agonist.
Systematic Name
2-[4-[(5,6-Diphenylpyrazin-2-Yl)-Propan-2-Ylamino]Butoxy]-N-Methylsulfonylacetamide
Brand Name(S)
Uptravi
Therapeutic Category
PA – hypertension
Suitable Formulations
Solid
Approvals
Developed